Clinical Trial Update: Neoadjuvant Chemoradiation With Bevacizumab for Chinese Rectal Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating neoadjuvant chemoradiation with bevacizumab for rectal adenocarcinoma in Chinese patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rectal Adenocarcinoma

Drugs mentioned

• Bevacizumab (bevacizumab)

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Rectal Adenocarcinoma | Phase 2 | Status: COMPLETED